Aimee Jackson

Person

Louisville, CO, US

People

Patents Grantslast 30 patents

Information Patent Grant
Oligonucleotide compositions and uses thereof
- Patent number 10,316,318
- Issue date Jun 11, 2019
- MiRagen Therapeutics, Inc.
- David Rodman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
MiR-92 inhibitors and uses thereof
- Patent number 10,280,422
- Issue date May 7, 2019
- MiRagen Therapeutics, Inc.
- Christina Marie Dalby
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide compositions and uses thereof
- Patent number 9,994,852
- Issue date Jun 12, 2018
- MiRagen Therapeutics, Inc.
- David Rodman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
miR-92 inhibitors and uses thereof
- Patent number 9,885,042
- Issue date Feb 6, 2018
- MiRagen Therapeutics, Inc.
- Christina Marie Dalby
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)
- Patent number 9,771,585
- Issue date Sep 26, 2017
- MiRagen Therapeutics, Inc.
- David Rodman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
miR29 MIMICS FOR THE TREATMENT OF OCULAR FIBROSIS
- Publication number 20200376019
- Publication date Dec 3, 2020
- MiRagen Therapeutics, Inc.
- Corrie Lynn GALLANT-BEHM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CUTANEOUS T-CELL LYMPHOMA (CTCL) WITH MIR-155...
- Publication number 20200276220
- Publication date Sep 3, 2020
- MiRagen Therapeutics, Inc.
- Aimee L. JACKSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGONUCLEOTIDE COMPOSITIONS AND USES THEREOF
- Publication number 20190359980
- Publication date Nov 28, 2019
- MiRagen Therapeutics, Inc.
- David RODMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MIR-92 INHIBITORS AND USES THEREOF
- Publication number 20190194662
- Publication date Jun 27, 2019
- MiRagen Therapeutics, Inc.
- Christina Marie Dalby
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDE COMPOSITIONS AND USES THEREOF
- Publication number 20190106695
- Publication date Apr 11, 2019
- MiRagen Therapeutics, Inc.
- David RODMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MIR-92 INHIBITORS AND USES THEREOF
- Publication number 20180237779
- Publication date Aug 23, 2018
- MiRagen Therapeutics, Inc.
- Christina Marie Dalby
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MIR-155 INHIBITORS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
- Publication number 20180161357
- Publication date Jun 14, 2018
- MiRagen Therapeutics, Inc.
- Aimee JACKSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MIR-155 INHIBITORS FOR TREATING CUTANEOUS T CELL LYMPHOMA (CTCL)
- Publication number 20180127750
- Publication date May 10, 2018
- MiRagen Therapeutics, Inc.
- David RODMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MIRNA MIMETICS AND THEIR USE IN TREATING SENSORY CONDITIONS
- Publication number 20180080023
- Publication date Mar 22, 2018
- MiRagen Therapeutics, Inc.
- Aimee L. JACKSON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDE COMPOSITIONS AND USES THEREOF
- Publication number 20180037890
- Publication date Feb 8, 2018
- MiRagen Therapeutics, Inc.
- David RODMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MIR-155 INHIBITORS FOR TREATING CUTANEOUS T CELL LYMPHOMA (CTCL)
- Publication number 20160355814
- Publication date Dec 8, 2016
- MiRagen Therapeutics, Inc.
- David RODMAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MIR-92 INHIBITORS AND USES THEREOF
- Publication number 20160208258
- Publication date Jul 21, 2016
- MiRagen Therapeutics, Inc.
- Christina Marie Dalby
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Aimee Jackson

Person

Patents Grantslast 30 patents

Oligonucleotide compositions and uses thereof

MiR-92 inhibitors and uses thereof

Oligonucleotide compositions and uses thereof

miR-92 inhibitors and uses thereof

miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)

Patents Applicationslast 30 patents

miR29 MIMICS FOR THE TREATMENT OF OCULAR FIBROSIS

METHODS FOR TREATING CUTANEOUS T-CELL LYMPHOMA (CTCL) WITH MIR-155...

OLIGONUCLEOTIDE COMPOSITIONS AND USES THEREOF

MIR-92 INHIBITORS AND USES THEREOF

OLIGONUCLEOTIDE COMPOSITIONS AND USES THEREOF

MIR-92 INHIBITORS AND USES THEREOF

MIR-155 INHIBITORS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

MIR-155 INHIBITORS FOR TREATING CUTANEOUS T CELL LYMPHOMA (CTCL)

MIRNA MIMETICS AND THEIR USE IN TREATING SENSORY CONDITIONS

OLIGONUCLEOTIDE COMPOSITIONS AND USES THEREOF

MIR-155 INHIBITORS FOR TREATING CUTANEOUS T CELL LYMPHOMA (CTCL)

MIR-92 INHIBITORS AND USES THEREOF